Found: 23
Select item for more details and to access through your institution.
A rapid and easy method for multiple endocrine neoplasia type 1 mutation detection using conformation-sensitive gel electrophoresis.
- Published in:
- Journal of Human Genetics, 2002, v. 47, n. 4, p. 190, doi. 10.1007/s100380200022
- By:
- Publication type:
- Article
G12S and H50R variations are polymorphisms in the SDHD gene.
- Published in:
- Genes, Chromosomes & Cancer, 2003, v. 37, n. 2, p. 220
- By:
- Publication type:
- Article
Reply to Dr. Rafael Rosell: Shedding some light on the unresolved issue of YAP1 Ser397 phosphorylation in cancer.
- Published in:
- 2024
- By:
- Publication type:
- Letter
Correction: Inhibition of the AURKA/YAP1 axis is a promising therapeutic option for overcoming cetuximab resistance in colorectal cancer stem cells.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Inhibition of the AURKA/YAP1 axis is a promising therapeutic option for overcoming cetuximab resistance in colorectal cancer stem cells.
- Published in:
- British Journal of Cancer, 2024, v. 130, n. 8, p. 1402, doi. 10.1038/s41416-024-02649-z
- By:
- Publication type:
- Article
Hypermethylation of P16<sup>ink4a</sup> and P15<sup>ink4b</sup> genes as a marker of disease in the follow-up of non-Hodgkin's lymphomas.
- Published in:
- British Journal of Haematology, 2000, v. 109, n. 1, p. 97, doi. 10.1046/j.1365-2141.2000.01991.x
- By:
- Publication type:
- Article
Combined 5-FU and ChoKα Inhibitors as a New Alternative Therapy of Colorectal Cancer: Evidence in Human Tumor-Derived Cell Lines and Mouse Xenografts.
- Published in:
- PLoS ONE, 2013, v. 8, n. 6, p. 1, doi. 10.1371/journal.pone.0064961
- By:
- Publication type:
- Article
Polymorphisms in the Initiators of RET (Rearranged during Transfection) Signaling Pathway and Susceptibility to Sporadic Medullary Thyroid Carcinoma.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2005, v. 90, n. 11, p. 6268, doi. 10.1210/jc.2004-2449
- By:
- Publication type:
- Article
Succinate Dehydrogenase D Variants Do Not Constitute a Risk Factor for Developing C Cell Hyperplasia or Sporadic Medullary Thyroid Carcinoma.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2005, v. 90, n. 4, p. 2127, doi. 10.1210/jc.2004-2059
- By:
- Publication type:
- Article
Erratum: Lights and shadows of proteomic technologies for the study of protein species including isoforms, splicing variants and protein post-translational modifications.
- Published in:
- Proteomics, 2011, v. 11, n. 7, p. 1370, doi. 10.1002/pmic.201190025
- By:
- Publication type:
- Article
Lights and shadows of proteomic technologies for the study of protein species including isoforms, splicing variants and protein post-translational modifications.
- Published in:
- Proteomics, 2011, v. 11, n. 4, p. 590, doi. 10.1002/pmic.201000287
- By:
- Publication type:
- Article
Functional PTGS2 polymorphism-based models as novel predictive markers in metastatic renal cell carcinoma patients receiving first-line sunitinib.
- Published in:
- Scientific Reports, 2017, p. 41371, doi. 10.1038/srep41371
- By:
- Publication type:
- Article
UNR/CDSE1 expression as prognosis biomarker in resectable pancreatic ductal adenocarcinoma patients: A proof-of-concept.
- Published in:
- PLoS ONE, 2017, v. 12, n. 8, p. 1, doi. 10.1371/journal.pone.0182044
- By:
- Publication type:
- Article
DEK is a potential marker for aggressive phenotype and irinotecan-based therapy response in metastatic colorectal cancer.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Ras Family of Small GTPases in CRC: New Perspectives for Overcoming Drug Resistance.
- Published in:
- Cancers, 2021, v. 13, n. 15, p. 3757, doi. 10.3390/cancers13153757
- By:
- Publication type:
- Article
Predictive value of vrk 1 and 2 for rectal adenocarcinoma response to neoadjuvant chemoradiation therapy: a retrospective observational cohort study.
- Published in:
- 2016
- By:
- Publication type:
- journal article
DEK is a potential marker for aggressive phenotype and irinotecan-based therapy response in metastatic colorectal cancer.
- Published in:
- BMC Cancer, 2014, v. 14, n. 1, p. 1, doi. 10.1186/1471-2407-14-965
- By:
- Publication type:
- Article
Targeting Galectin-1 by Aflibercept Strongly Enhances Its Antitumor Effect in Neuroendocrine Carcinomas.
- Published in:
- Neuroendocrinology, 2021, v. 111, n. 1/2, p. 146, doi. 10.1159/000506163
- By:
- Publication type:
- Article
Strong Antitumor Activity of Bevacizumab and Aflibercept in Neuroendocrine Carcinomas: In-Depth Preclinical Study.
- Published in:
- Neuroendocrinology, 2020, v. 110, n. 1/2, p. 50, doi. 10.1159/000500591
- By:
- Publication type:
- Article
Molecular analysis of the BRCA2 gene in 16 breast/ovarian cancer Spanish families.
- Published in:
- Clinical Genetics, 1998, v. 54, n. 2, p. 142, doi. 10.1111/j.1399-0004.1998.tb03717.x
- By:
- Publication type:
- Article
Focal adhesion kinase: predictor of tumour response and risk factor for recurrence after neoadjuvant chemoradiation in rectal cancer.
- Published in:
- Journal of Cellular & Molecular Medicine, 2016, v. 20, n. 9, p. 1729, doi. 10.1111/jcmm.12879
- By:
- Publication type:
- Article
Choline Kinase α Inhibitors MN58b and RSM932A Enhances the Antitumor Response to Cisplatin in Lung Tumor Cells.
- Published in:
- Pharmaceutics, 2022, v. 14, n. 6, p. 1143, doi. 10.3390/pharmaceutics14061143
- By:
- Publication type:
- Article
Approaches for the study of cancer: towards the integration of genomics, proteomics and metabolomics.
- Published in:
- Clinical & Translational Oncology, 2011, v. 13, n. 9, p. 617, doi. 10.1007/s12094-011-0707-9
- By:
- Publication type:
- Article